IARC News

Vacancy, Director, IARC

Applications from highly qualified persons are invited for the post of Director, IARC. The appointment of the Director will be made in May 2018 for a term of five years beginning on 1 January 2019. The selected candidate may be eligible for one further five-year term.

The deadline for the receipt of applications is the closure of working hours on 15 February 2018.
Download application form

Métropole de Lyon and IARC unveil plans for new IARC building

After an 18-month international competitive bidding process for the design and construction of the “Nouveau Centre” (combined design-build contract) for the International Agency for Research on Cancer (IARC), the winning team has been selected by the Métropole de Lyon. The team consists of Demathieu Bard (general contractor), Art&Build (architects), Unanime (architects), WSP (design engineering company), and Inddigo (sustainable development engineering company). The project is managed by the Métropole de Lyon and funded by the French government, the Métropole de Lyon, the Région Auvergne-Rhône-Alpes, and the Ville de Lyon.
More information

IARC Internal Seminar: 11th Richard Doll Lecture: Opium as a carcinogen: new insights from the Golestan Cohort Study

15/01/2018 11th Richard Doll Lecture
Title: Opium as a carcinogen: new insights from the Golestan Cohort Study
Speaker: Professor Reza Malekzadeh, Director, Digestive Disease Research Center, Tehran University of Medical Sciences, Iran
Watch video

Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice

12/01/2018 Cutaneous beta human papillomavirus (HPV) types are suspected to be involved, together with ultraviolet (UV) radiation, in the development of non-melanoma skin cancer, the most common form of human cancer. A new study by researchers from the International Agency for Research on Cancer (IARC) and the German Cancer Research Center (DKFZ), published today in PLoS Pathogens, used a transgenic mouse model in which the expression of beta HPV38 oncogenes can be modulated in the skin. Their findings support the concept that beta HPV types act only at an initial stage of carcinogenesis, by potentiating the deleterious effects of UV radiation.

Viarisio D, Müller-Decker K, Accardi R, Robitaille A, Dürst M, Beer K, et al.
Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice
PLoS Pathog, Published online 11 January 2018
http://dx.doi.org/10.1371/journal.ppat.1006783
Read article, Read more

Publications

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues

07/09/2017 The WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues is a Revised 4th Edition Volume of the WHO series on histological and genetic typing of human tumours. This authoritative, concise reference book provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies monitoring response to therapy and clinical outcome.

This classification, prepared by 132 authors from 23 countries, contains about 1300 colour images and tables, and more than 4500 references.
Read more








Cancer Today

ESTIMATED CANCER
INCIDENCE,
MORTALITY AND PREVALENCE
WORLDWIDE IN 2012

Cancer Today is part of the Global Cancer Observatory website.

FACT SHEETS